4.8 Article

SALL4 promotes glycolysis and chromatin remodeling via modulating HP1α-Glut1 pathway

期刊

ONCOGENE
卷 36, 期 46, 页码 6472-6479

出版社

SPRINGERNATURE
DOI: 10.1038/onc.2017.265

关键词

-

资金

  1. National Natural Science Foundation of China [815300045, 81373166, 81430032]
  2. National High-tech R&D Program (863 Program) [2015AA020310]
  3. Guangdong Provincial Key Laboratory of Tumor Immunotherapy, South Wisdom Valley Innovative Research Team Program [365]
  4. Major basic research developmental project of the Natural Science Foundation of Guangdong Province
  5. Shenzhen Municipal Science and Technology Innovation Council [20140405201035]
  6. California Institute for Regenerative Medicine [TR3-05559, RT3-07899]
  7. Guangzhou Key Laboratory of Tumor Immunology Research, South Wisdom Valley Innovative Research Team Program [365]

向作者/读者索取更多资源

SALL4 has recently been identified to promote chemo-resistance in multiple types of cancer, but the underlying mechanism remains to be fully established. Open chromatin structure is important for DNA damage response (DDR) and DNA repair. Here, we demonstrate that SALL4 promotes open chromatin by destabilizing heterochromatin protein 1a (HP1a) by recruiting ubiquitin E3 ligase CUL4B to HP1 alpha. The silencing of SALL4 in cancer cells decreased the expression levels of Glut1 and inhibited glycolysis in cancer cells. The upregulation of HP1 alpha in human cancer cells suppressed open chromatin, glycolysis and Glut1 expression levels. Therefore, SALL4 promotes the expression of Glut1 and open chromatin through a HP1 alpha-dependent mechanism. Impaired DDR in SALL4-deficient human cancer cells can be rescued by the restored expression of Glut1, indicating the importance of HP1 alpha-Glut1 axis in SALL4-mediated DDR. These findings demonstrate that SALL4 could induce drug resistance by enhancing DDR and DNA repair through promoting glycolysis and subsequent chromatin remodeling.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据